Stock Yards Bank & Trust’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$709K Buy
3,594
+37
+1% +$7.13K 0.02% 247
2025
Q4
$654K Hold
3,557
0.02% 252
2025
Q3
$546K Buy
3,557
+216
+6% +$32.7K 0.02% 274
2025
Q2
$467K Sell
3,341
-725
-18% -$102K 0.02% 285
2025
Q1
$598K Buy
4,066
+8
+0.2% +$1.16K 0.02% 242
2024
Q4
$532K Buy
4,058
+612
+18% +$85.7K 0.02% 255
2024
Q3
$537K Buy
3,446
+36
+1% +$5.81K 0.02% 268
2024
Q2
$532K Sell
3,410
-150
-4% -$22.6K 0.02% 267
2024
Q1
$482K Buy
3,560
+13
+0.4% +$1.72K 0.02% 284
2023
Q4
$478K Sell
3,547
-48
-1% -$6.24K 0.02% 281
2023
Q3
$487K Sell
3,595
-162
-4% -$22.1K 0.02% 270
2023
Q2
$538K Sell
3,757
-33
-0.9% -$4.86K 0.02% 273
2023
Q1
$526K Buy
3,790
+368
+11% +$49.5K 0.02% 277
2022
Q4
$464K Buy
3,422
+135
+4% +$16.9K 0.02% 301
2022
Q3
$360K Sell
3,287
-420
-11% -$53.3K 0.02% 318
2022
Q2
$490K Buy
+3,707
New +$486K 0.02% 291

Other funds holding AZN

Stock Yards Bank & Trust's AZN Position: Q1 2026 in Review

Stock Yards Bank & Trust increased its AstraZeneca (AZN) stake by 1% in Q1 2026, buying an estimated $7.13K and bringing the position to 3,594 shares worth $709K. The position accounts for 0.02% of the portfolio, ranked #247.

Stock Yards Bank & Trust first reported a position in AZN in Q2 2022 and has held it in 16 quarters since. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • Stock Yards Bank & Trust held 3,594 shares of AstraZeneca worth $709K as of Q1 2026.
  • Stock Yards Bank & Trust bought 37 AstraZeneca shares in Q1 2026, an estimated $7.13K.
  • AstraZeneca made up 0.02% of Stock Yards Bank & Trust's portfolio in Q1 2026, its #247 holding.
  • Stock Yards Bank & Trust first reported a position in AstraZeneca in Q2 2022 and has held it in 16 quarters since.
  • 1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Stock Yards Bank & Trust's 13F filing for Q1 2026, filed 24 Apr 2026.